Purell Advanced Soothing
Alcohol
Gojo Industries, Inc.
Human Otc Drug
NDC 21749-713Purell Advanced Soothing also known as Alcohol is a human otc drug labeled by 'Gojo Industries, Inc.'. National Drug Code (NDC) number for Purell Advanced Soothing is 21749-713. This drug is available in dosage form of Gel. The names of the active, medicinal ingredients in Purell Advanced Soothing drug includes Alcohol - .7 mL/mL . The currest status of Purell Advanced Soothing drug is Active.
Drug Information:
| Drug NDC: | 21749-713 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Purell Advanced Soothing |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Alcohol |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Gojo Industries, Inc. |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Gel |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | ALCOHOL - .7 mL/mL
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | TOPICAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | OTC MONOGRAPH NOT FINAL |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 01 Nov, 2018 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 22 Dec, 2025 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Application Number: | part333E |
| This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null. |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | GOJO Industries, Inc.
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| RxCUI: | 581662
|
| The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UNII: | 3K9958V90M
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 21749-713-01 | 30 mL in 1 PACKAGE (21749-713-01) | 01 Nov, 2018 | N/A | No |
| 21749-713-02 | 59 mL in 1 BOTTLE (21749-713-02) | 01 Nov, 2018 | N/A | No |
| 21749-713-04 | 118 mL in 1 PACKAGE (21749-713-04) | 01 Nov, 2018 | N/A | No |
| 21749-713-08 | 236 mL in 1 BOTTLE (21749-713-08) | 01 Nov, 2018 | N/A | No |
| 21749-713-10 | 295 mL in 1 PACKAGE (21749-713-10) | 01 Nov, 2018 | N/A | No |
| 21749-713-12 | 354 mL in 1 BOTTLE (21749-713-12) | 01 Nov, 2018 | N/A | No |
| 21749-713-20 | 591 mL in 1 PACKAGE (21749-713-20) | 01 Nov, 2018 | N/A | No |
| 21749-713-24 | 710 mL in 1 PACKAGE (21749-713-24) | 01 Aug, 2021 | N/A | No |
| 21749-713-27 | 800 mL in 1 PACKAGE (21749-713-27) | 01 Nov, 2018 | N/A | No |
| 21749-713-28 | 826 mL in 1 PACKAGE (21749-713-28) | 01 Nov, 2018 | N/A | No |
| 21749-713-33 | 1000 mL in 1 PACKAGE (21749-713-33) | 01 Nov, 2018 | N/A | No |
| 21749-713-40 | 1200 mL in 1 PACKAGE (21749-713-40) | 01 Nov, 2018 | N/A | No |
| 21749-713-65 | 192 mL in 1 PACKAGE (21749-713-65) | 01 Jul, 2021 | N/A | No |
| 21749-713-67 | 2000 mL in 1 PACKAGE (21749-713-67) | 01 Nov, 2018 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Purpose antimicrobial
Product Elements:
Purell advanced soothing alcohol alcohol alcohol water isopropyl alcohol aloe vera leaf caprylyl glycol glycerin isopropyl myristate .alpha.-tocopherol acetate, d- aminomethylpropanol fd&c blue no. 1 fd&c yellow no. 5
Indications and Usage:
Uses hand sanitizer to help reduce bacteria on the skin
Warnings:
Warnings flammable. keep away from fire or flame. for external use only when using this product do not use in or near the eyes. in case of contact, rinse eyes thoroughly with water. stop use and ask a doctor if irritation or rash appears and lasts keep out of reach of children. if swallowed, get medical help or contact a poison control center right away.
When Using:
When using this product do not use in or near the eyes. in case of contact, rinse eyes thoroughly with water.
Dosage and Administration:
Directions put enough product in your palm to cover hands and rub hands together briskly until dry children under 6 years of age should be supervised when using purell
Stop Use:
Stop use and ask a doctor if irritation or rash appears and lasts
Package Label Principal Display Panel:
Product label